Susan R. Kahn

42.1k total citations · 11 hit papers
330 papers, 25.8k citations indexed

About

Susan R. Kahn is a scholar working on Internal Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Susan R. Kahn has authored 330 papers receiving a total of 25.8k indexed citations (citations by other indexed papers that have themselves been cited), including 275 papers in Internal Medicine, 133 papers in Surgery and 131 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Susan R. Kahn's work include Venous Thromboembolism Diagnosis and Management (275 papers), Diagnosis and Treatment of Venous Diseases (119 papers) and Atrial Fibrillation Management and Outcomes (98 papers). Susan R. Kahn is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (275 papers), Diagnosis and Treatment of Venous Diseases (119 papers) and Atrial Fibrillation Management and Outcomes (98 papers). Susan R. Kahn collaborates with scholars based in Canada, United States and France. Susan R. Kahn's co-authors include Clive Kearon, Anthony J. Comerota, Samuel Z. Goldhaber, Paolo Prandoni, Elie A. Akl, Francesco Dentali, Philip S. Wells, Mark Crowther, Ian Shrier and Henri Bounameaux and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Susan R. Kahn

318 papers receiving 24.9k citations

Hit Papers

Antithrombotic Therapy fo... 2003 2026 2010 2018 2012 2012 2008 2003 2008 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan R. Kahn Canada 70 20.3k 11.5k 10.0k 5.4k 4.2k 330 25.8k
John A. Heit United States 68 23.7k 1.2× 15.2k 1.3× 9.3k 0.9× 4.3k 0.8× 6.5k 1.6× 220 30.9k
Menno V. Huisman Netherlands 76 20.0k 1.0× 15.5k 1.3× 5.8k 0.6× 3.5k 0.6× 3.2k 0.8× 469 29.6k
Sam Schulman Canada 69 21.5k 1.1× 21.5k 1.9× 7.1k 0.7× 2.4k 0.4× 7.7k 1.9× 501 34.5k
Philip S. Wells Canada 63 14.9k 0.7× 10.4k 0.9× 5.6k 0.6× 3.2k 0.6× 3.2k 0.8× 299 19.7k
Michael Gent Canada 90 16.1k 0.8× 20.2k 1.8× 9.1k 0.9× 2.6k 0.5× 5.1k 1.2× 230 34.9k
Tanya M. Petterson United States 42 8.5k 0.4× 5.6k 0.5× 3.3k 0.3× 1.7k 0.3× 3.0k 0.7× 104 12.9k
Gary E. Raskob United States 58 13.3k 0.7× 11.1k 1.0× 4.8k 0.5× 2.3k 0.4× 3.2k 0.8× 170 19.6k
Richard H. White United States 61 8.5k 0.4× 5.5k 0.5× 4.0k 0.4× 2.0k 0.4× 2.6k 0.6× 242 15.9k
Marc D. Silverstein United States 49 6.6k 0.3× 4.3k 0.4× 3.8k 0.4× 1.6k 0.3× 2.0k 0.5× 123 13.9k
Saskia Middeldorp Netherlands 62 8.0k 0.4× 5.7k 0.5× 2.9k 0.3× 684 0.1× 5.8k 1.4× 369 16.5k

Countries citing papers authored by Susan R. Kahn

Since Specialization
Citations

This map shows the geographic impact of Susan R. Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan R. Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan R. Kahn more than expected).

Fields of papers citing papers by Susan R. Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan R. Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan R. Kahn. The network helps show where Susan R. Kahn may publish in the future.

Co-authorship network of co-authors of Susan R. Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Susan R. Kahn. A scholar is included among the top collaborators of Susan R. Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan R. Kahn. Susan R. Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Righini, Marc, Sam Schulman, Venkatesh Thiruganasambandamoorthy, et al.. (2025). Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study. Journal of Thrombosis and Haemostasis. 23(10). 3239–3250.
2.
Cimini, Ludovica Anna, Stefano Barco, Waleed Ghanima, et al.. (2024). Pulmonary perfusion defects or residual vascular obstruction and persistent symptoms after pulmonary embolism: a systematic review and meta-analysis. ERJ Open Research. 10(4). 1010–2023. 4 indexed citations
3.
King, James A., Jenny Godley, Deborah Siegal, et al.. (2024). Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemic. PubMed. 1(1). 100004–100004. 1 indexed citations
4.
Kahn, Susan R., et al.. (2023). TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol. BMJ Open. 13(10). e064715–e064715. 1 indexed citations
5.
Rodger, Marc, Waleed Ghanima, Michael J. Kovacs, et al.. (2023). Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study. Thrombosis and Haemostasis. 123(7). 692–699. 2 indexed citations
6.
Carrier, Marc, Catherine Sperlich, Susan Solymoss, et al.. (2022). Step down to 6 months of prophylactic‐dose low molecular weight heparin after initial full‐dose anticoagulation for the treatment of cancer‐associated thrombosis (STEP‐CAT): A pilot study. Journal of Thrombosis and Haemostasis. 20(8). 1868–1874. 1 indexed citations
7.
Tritschler, Tobias, Steven Salvatore, Susan R. Kahn, et al.. (2021). ISTH definition of pulmonary embolism‐related death and classification of the cause of death in venous thromboembolism studies: Validation in an autopsy cohort. Journal of Thrombosis and Haemostasis. 19(10). 2514–2521. 1 indexed citations
8.
Lee, Amanda, Chu‐Shu Gu, Suresh Vedantham, et al.. (2021). Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndrome. Journal of Vascular Surgery Venous and Lymphatic Disorders. 9(5). 1257–1265.e2. 5 indexed citations
9.
Vedantham, Suresh, et al.. (2021). Clinical Outcomes of a Pharmacomechanical Catheter-Directed Venous Thrombolysis Strategy that Included Rheolytic Thrombectomy in a Multicenter Randomized Trial. Journal of Vascular and Interventional Radiology. 32(9). 1296–1309.e7. 24 indexed citations
10.
Wit, Kerstin de, Sam Schulman, Fred Spencer, et al.. (2020). Deep Vein Thrombosis Diagnosis with D-Dimer Adjusted to Clinical Probability. Blood. 136(Supplement 1). 20–20. 1 indexed citations
11.
Comerota, Anthony J., Clive Kearon, Chu‐Shu Gu, et al.. (2020). Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis. Journal of Vascular Surgery Venous and Lymphatic Disorders. 8(2). 306–307. 3 indexed citations
12.
Righini, Marc, Helia Robert‐Ebadi, Fréderic Glauser, et al.. (2019). Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis. 17(3). 507–510. 8 indexed citations
13.
Schünemann, Holger J., Mary Cushman, Allison Burnett, et al.. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Advances. 2(22). 3198–3225. 467 indexed citations breakdown →
14.
Carrier, Marc, Judy Kovacs, Marc Rodger, et al.. (2017). Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode. Journal of Thrombosis and Haemostasis. 15(10). 1977–1980. 2 indexed citations
15.
Lazo‐Langner, Alejandro, Susan R. Kahn, Philip S. Wells, et al.. (2016). Post-Thrombotic Syndrome and Functional Disability in Patients with Upper Extremity Deep Vein Thrombosis: A Prospective Cohort Study. Blood. 128(22). 417–417. 3 indexed citations
16.
Kramer, Michael S., Susan R. Kahn, Robert W. Platt, et al.. (2009). Mid-trimester maternal plasma cytokines and CRP as predictors of spontaneous preterm birth. Cytokine. 49(1). 10–14. 35 indexed citations
17.
Rey, Évelyne, Pierre Y. Garneau, Matthias David, et al.. (2009). Dalteparin for the Prevention of Recurrence of Placental-Mediated Complications of Pregnancy in Women Without Thrombophilia: A Pilot Randomized Controlled Trial. Obstetrical & Gynecological Survey. 64(6). 357–358. 7 indexed citations
18.
Kahn, Susan R., Clive Kearon, J.A. Julian, et al.. (2005). Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis. Journal of Thrombosis and Haemostasis. 3(4). 718–723. 147 indexed citations
19.
Tagalakis, Vicky, Susan R. Kahn, Michael Libman, & Mark Blostein. (2002). The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. The American Journal of Medicine. 113(2). 146–151. 201 indexed citations
20.
Kahn, Susan R., et al.. (2000). Long-term outcomes after deep vein thrombosis: Postphlebitic syndrome and quality of life. Journal of General Internal Medicine. 15(6). 425–429. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026